חזרה לתוצאות החיפוש

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

C3 Glomerulopathy · Immune-complex-membranoproliferative Glomerulonephritis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Novartis Investigative Site, Petah Tikva, Israel

  • Novartis Investigative Site, Petah Tikva, Israel

  • Childrens Hospital Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Kati Dugan) · Kati.Dugan@childrenscolorado.org · +1 720 777 6895
    Contact: Principal Investigator (Bradley Dixon)

  • Georgia Nephrology Research Inst, Lawrenceville, Georgia, United States

    Contact: Study coordinator (Lisa Franklin) · lfranklin@ganephrology.com · +1 404 645 7850#3024
    Contact: Principal Investigator (James A Tumlin)

  • University of Iowa Health Care, Iowa City, Iowa, United States

    Contact: Study coordinator (Nicole Gerot) · nicole-gerot@uiowa.edu · +1 319 335 7555
    Contact: Principal Investigator (Carla Nester)

  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Brady Wallner) · walln080@umn.edu
    Contact: Principal Investigator (Nattawat Klomjit)

  • Col Uni Med Center New York Presby, New York, New York, United States

    Contact: Study coordinator (Brianna Ortiz) · bo2323@cumc.columbia.edu · +1 212 304 5684
    Contact: Principal Investigator (Andrew S Bomback)

  • Novartis Investigative Site, CABA, Buenos Aires, Argentina

  • Novartis Investigative Site, Buenos Aires, Argentina

  • Novartis Investigative Site, Belo Horizonte, Minas Gerais, Brazil

  • Novartis Investigative Site, Recife, Pernambuco, Brazil

  • Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, Brazil

  • Novartis Investigative Site, Botucatu, São Paulo, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Salvador, Brazil

  • Novartis Investigative Site, Toronto, Ontario, Canada

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Prague, Czechia

  • Novartis Investigative Site, Montpellier, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Toulouse, France

  • Novartis Investigative Site, Erlangen, Germany

  • Novartis Investigative Site, Essen, Germany

  • Novartis Investigative Site, Hamburg, Germany

  • Novartis Investigative Site, Heidelberg, Germany

  • Novartis Investigative Site, Mainz, Germany

  • Novartis Investigative Site, Heraklion Crete., Greece

  • Novartis Investigative Site, Thessaloniki, Greece

  • Novartis Investigative Site, Bari, BA, Italy

  • Novartis Investigative Site, Ranica, BG, Italy

  • Novartis Investigative Site, Roma, RM, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Asahikawa, Hokkaido, Japan

  • Novartis Investigative Site, Sapporo, Hokkaido, Japan

  • Novartis Investigative Site, Takatsuki, Osaka, Japan

  • Novartis Investigative Site, Ohtsu, Shiga, Japan

  • Novartis Investigative Site, Hachiōji, Tokyo, Japan

  • Novartis Investigative Site, Niigata, Japan

  • Novartis Investigative Site, Leiden, South Holland, Netherlands

  • Novartis Investigative Site, Pamplona, Navarre, Spain

  • Novartis Investigative Site, Barcelona, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Seville, Spain

  • Novartis Investigative Site, Bern, Switzerland

  • Novartis Investigative Site, Köseköy, Kocaeli, Turkey (Türkiye)

  • Novartis Investigative Site, Kayseri, Melikgazi, Turkey (Türkiye)

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Newcastle upon Tyne, Tyne and Wear, United Kingdom

  • Novartis Investigative Site, Cardiff, United Kingdom

  • Novartis Investigative Site, London, United Kingdom

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)